NewsBenzingaHC Wainwright & Co.、Immix Biopharmaの「買い」評価を維持、目標株価を27ドルに引き上げ HC Wainwright & Co.、Immix Biopharmaの「買い」評価を維持、目標株価を27ドルに引き上げ Benzinga 2026.11.16 12:29 (GMT+0) Open on Benzinga Other news HKMA, Swift Explore Cross-Border Tokenized Payments FirstSource Stock Outlook: Is Wall Street Bullish or Bearish? What Are Wall Street Analysts' Target Price for Alliant Energy Stock? Public Service Enterprise Stock: Analyst Estimates & Ratings Are Wall Street Analysts Bullish on FirstEnergy Stock? DuPont de Nemours Stock: Is Wall Street Bullish or Bearish?